Lineage Cell Therapeutics (LCTX) Current Leases (2014 - 2026)
Lineage Cell Therapeutics' Current Leases came in at $33,000 for Q2 2026, down 34.0% from $50,000 a year earlier but up 3.1% from the prior quarter.
Powered by 
Analysis
Lineage Cell Therapeutics (LCTX) Current Leases (2014 - 2026) Analysis & Trends
At the end of FY2025, Lineage Cell Therapeutics' Current Leases was $37,000, down 32.7% from FY2024.
- Current Leases carries a five-year compound annual growth rate of 18.3% (FY2020 to FY2025).
- Going back by year, Current Leases was $55,000 in FY2024 (+5.8%), $52,000 in FY2023 (+44.4%), $36,000 in FY2022 (+20.0%) and $30,000 in FY2021 (+87.5%).
- The five-year range for quarterly Current Leases is $17,000 (Q3 2021) to $56,000 (Q1 2025).
- Year-over-year, Current Leases has declined for four consecutive quarters, with an average decline of 12.9% over the last eight quarters.
- The fastest year-over-year change in Current Leases over five years came in Q3 2023 (growth of 120.0%), and the weakest in Q3 2021 (a decline of 96.5%).
- Business Quant data shows LCTX's Current Leases at $32,000 (Q1 2026), $37,000 (Q4 2025) and $43,000 (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | - |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | - |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 274.00 Mn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -2.32 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | - |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | - |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | - |
| 10 | Lineage Cell Therapeutics | 245.32 Mn | 43.73 Mn | - | 33,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 33,000.00 |
| Mar 31, 2026 | 32,000.00 |
| Dec 31, 2025 | 37,000.00 |
| Sep 30, 2025 | 43,000.00 |
| Jun 30, 2025 | 50,000.00 |
| Mar 31, 2025 | 56,000.00 |
| Dec 31, 2024 | 55,000.00 |
| Sep 30, 2024 | 54,000.00 |
| Jun 30, 2024 | 46,000.00 |
| Mar 31, 2024 | 49,000.00 |
| Dec 31, 2023 | 52,000.00 |
| Sep 30, 2023 | 55,000.00 |
| Jun 30, 2023 | 54,000.00 |
| Mar 31, 2023 | 51,000.00 |
| Dec 31, 2022 | 36,000.00 |
| Sep 30, 2022 | 25,000.00 |
| Jun 30, 2022 | 29,000.00 |
| Mar 31, 2022 | 31,000.00 |
| Dec 31, 2021 | 30,000.00 |
| Sep 30, 2021 | 17,000.00 |
API Access
Lineage Cell Therapeutics Current Leases API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-leases&ticker=LCTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-leases", "ticker": "LCTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-leases&ticker=LCTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();